Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.
Condition(s):Pain; Intravitreal Injection; Pain, AcuteLast Updated:February 9, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Pain; Intravitreal Injection; Pain, AcuteLast Updated:February 9, 2024Completed
Condition(s):Rhegmatogenous Retinal Detachment; Proliferative VitreoretinopathyLast Updated:April 26, 2023Recruiting
Condition(s):Glaucoma, Open-AngleLast Updated:May 3, 2023Recruiting
Condition(s):Primary Open Angle GlaucomaLast Updated:July 5, 2022Recruiting
Condition(s):Epiretinal Membrane; Macular HolesLast Updated:July 7, 2020Unknown status
Condition(s):Open Angle Glaucoma; Primary Open Angle Glaucoma; Pigmentary Glaucoma; Pseudoexfoliation Glaucoma in Both EyesLast Updated:February 21, 2021Withdrawn
Condition(s):Glaucoma, Open-AngleLast Updated:June 29, 2022Completed
Condition(s):Glaucoma, Primary Open AngleLast Updated:May 3, 2023Recruiting
Condition(s):Retinitis PigmentosaLast Updated:May 10, 2019Withdrawn
Condition(s):Glaucoma; Ocular HypertensionLast Updated:March 29, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.